Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Therapeutic Advances in Neurological Disorders|November 21, 2025
Reporting patterns of multiple sclerosis with immune checkpoint inhibitors: analysis of the FDA Adverse Event Reporting SystemAfsaneh Shirani, Samuel A Goldlust, Olaf Stuve
Journal of Neuro-Oncology|March 17, 2006
Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patientsHerbert B Newton, Samuel A Goldlust, Dennis Pearl
Current Pain and Headache Reports|October 8, 2010
Headache in patients with cancerSamuel A Goldlust, Jerome J Graber, Dana F Bossert, et al.
Anesthesiology|August 2, 2002
Randomized prospective comparison of forced air warming using hospital blankets versus commercial blankets in surgical patientsAbdallah Kabbara, Samuel A Goldlust, Charles E Smith, et al.
Journal of Neuro-Oncology|December 29, 2011
Bevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitorsSamuel A Goldlust, Robert Cavaliere, Herbert B Newton, et al.
World Neurosurgery|May 31, 2025
En Bloc Spondylectomy versus Separation Surgery for Spinal Metastases: A Systematic Review and Meta-AnalysisAhmad K AlMekkawi, Ashlesha Bhojane, Brandon Edelbach, et al.
The Oncologist|October 14, 2024
Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastomaSimon Khagi, Rupesh Kotecha, Na Tosha N Gatson, et al.
Neuro-Oncology Advances|February 8, 2024
Phase 1 trial of TPI 287, a microtubule stabilizing agent, in combination with bevacizumab in adults with recurrent glioblastomaSamuel A Goldlust, Louis B Nabors, Sigmund Hsu, et al.
Pageof 2